Outcomes of treatment, laboratory results, adverse effects, and tolerability of cancer treatment in patients with metastatic renal cell carcinoma treated with cabozantinib after cytoreductive nephrectomy
INTRODUCTION: This publication aims to present the results of a retrospective analysis of the treatment outcomesof patients with metastatic renal cell carcinoma (mRCC) treated with cabozantinib who underwent cytoreductivenephrectomy (CN), radical nephrectomy (RN) or nephron-sparing surgery (NSS) and...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Via Medica
2025-12-01
|
| سلاسل: | Nowotwory |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/view/106245 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|